鲁西化工(000830) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥7,289,926,095.44, representing a 7.96% increase compared to ¥6,752,410,775.07 in the same period last year[3]. - Net profit attributable to shareholders decreased by 27.30% to ¥412,911,727.90 from ¥567,930,861.53 year-on-year[3]. - The net profit after deducting non-recurring gains and losses fell by 33.81% to ¥383,707,935.48 compared to ¥579,719,516.96 in the previous year[3]. - The company's profit before tax decreased by 32.57%, primarily due to a decline in the selling prices of certain chemical products, which affected gross margins[16]. - Net profit for the current period was ¥413,121,862.95, a decrease of 27.29% from ¥567,870,925.46 in the previous period[30]. - Operating profit decreased to ¥490,888,079.55, down 34.19% from ¥745,762,022.38 in the prior period[30]. - The total comprehensive income for the current period was ¥412,738,920.70, a decrease of 27.36% from ¥568,097,387.09 in the previous period[30]. Cash Flow - The net cash flow from operating activities increased by 4.93% to ¥1,468,071,219.31 from ¥1,399,091,268.65 year-on-year[3]. - Cash flow from operating activities generated a net amount of ¥1,468,071,219.31, an increase of 4.93% compared to ¥1,399,091,268.65 in the previous period[32]. - Cash flow from investing activities resulted in a net outflow of ¥535,509,215.60, worsening from a net outflow of ¥447,250,680.07 in the prior period[32]. - Cash flow from financing activities showed a net outflow of ¥1,022,328,018.65, compared to a net outflow of ¥707,685,237.33 in the previous period[32]. Assets and Liabilities - Total assets at the end of the reporting period were ¥36,116,685,320.54, a decrease of 0.42% from ¥36,268,449,915.13 at the end of the previous year[3]. - The total assets of the company as of March 31, 2025, amounted to CNY 36,116,685,320.54, a slight decrease from CNY 36,268,449,915.13 at the beginning of the period[25]. - Current assets increased to CNY 3,254,119,905.73 from CNY 3,027,371,115.19, reflecting a growth of approximately 7.5%[25]. - Inventory levels rose significantly to CNY 2,038,418,825.52, up from CNY 1,737,140,742.27, indicating an increase of about 17.4%[25]. - Short-term borrowings decreased to CNY 4,311,558,269.43 from CNY 4,770,458,910.35, a reduction of approximately 9.6%[26]. - Total liabilities decreased to CNY 16,875,925,042.31 from CNY 17,452,341,636.98, showing a decline of about 3.3%[26]. - The company's equity attributable to shareholders increased to CNY 19,105,592,322.18 from CNY 18,681,150,457.15, reflecting a growth of approximately 2.3%[27]. - Long-term borrowings decreased to CNY 3,263,080,000.00 from CNY 3,920,580,000.00, a reduction of approximately 16.7%[26]. - The total non-current assets decreased slightly to CNY 32,862,565,414.81 from CNY 33,241,078,799.94, a decline of approximately 1.1%[26]. Expenses - The company's R&D expenses decreased by 30.44% year-on-year, attributed to differences in the R&D project phases and content[11]. - Sales expenses increased by 93.75% year-on-year due to enhanced market expansion efforts and increased salaries and travel expenses for sales personnel[10]. - The company reported a decrease in research and development expenses to ¥164,365,114.60, down 30.39% from ¥236,279,584.44 in the prior period[29]. Return on Equity - The weighted average return on equity decreased to 2.19% from 3.30% in the previous year, reflecting a decline of 1.11%[3].